Monday, 16 November 2026Follow on 𝕏

Regulatory

Regulatory

China approves Bayer blood thinner asundexian

China’s drug regulator has approved Bayer’s (BAYN) blood thinner asundexian, a potential boost for the German drugmaker in the world’s second-largest pharmaceutical market as it moves to counter competition from generic medicines.